CD BioGlyco has rich experience in peptidoglycan structural analysis. Our multiple technology platforms and well-trained researchers can help customers get results quickly and accurately in the case of low-abundance samples. We have confidence to be your essential research assistant in the field of glycobiology.

Background

Peptidoglycan (PG, also known as murein) exists in the cell walls of gram-positive bacteria and gram-negative bacteria in eubacteria. The backbone of peptidoglycan is a polysaccharide chain formed by two sugar derivatives: N-acetylglucosamine (GlcNAc) and N-acetylmuramic acid (MurNAc) that alternately connected by β-1,4-glycosidic bonds. Two parallel sugar chains are connected laterally to form a network of peptidoglycan. PG is essential for maintaining cell integrity because of its ability to withstand turgor pressure. Any external force that affects its biosynthesis or degradation will interfere with cell viability. Therefore, PG is one of the main targets of antibacterial drugs. The study of peptidoglycan structure also plays a vital role in understanding the immune response, phage susceptibility and serological behavior, as well as the classification and identification of bacteria. Although the structure and architecture of PG have been studied for a long time, its detailed 3D structure is still an open question.

Key Technologies

CD BioGlyco provides a one-stop service to assist in studies from PG separation to structural analysis, and each process is strictly controlled by experienced researchers. The experimental operations are built on our multiple technology platforms, including but not limited to:

• Amino acid analyzers
• Thin layer chromatography (TLC)
• High-pH anion-exchange chromatography (HPAEC)
• High-performance liquid chromatography/ultra-performance liquid chromatography HPLC/UPLC-MS
• High performance anion exchange chromatography with pulsed amperometric detection (HPAEC-PAD)
• Matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS)
• Ion trap mass spectrometry (Q-Trap MS)
• Electrospray ionization-mass spectrometry (ESI-MS)
• Liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS)
• Nuclear magnetic resonance (NMR)
• Cryotransmission electron microscopy/Atomic force microscopy (cryo-TEM/AFM)

Fig.1 Key components of peptidoglycan structural analysis.

Unlocking the Secrets of the Microbial World: Advanced Carbohydrate Purification and Analysis Services

Our streamlined workflow ensures a comprehensive and efficient process, from initial consultation to final product delivery. Our team of experts works closely with you to tailor each step to your project's specific needs.

• Bacterial Culturing and Harvest

We begin by growing the specified bacterial strain under optimized conditions to ensure high biomass. The cells are then harvested, washed, and prepared for the extraction process.

• Extraction and Initial Purification

The prepared bacterial cells are subjected to a carefully selected extraction method (e.g., phenol-water, butanol, or a proprietary method) to release the target carbohydrates from the cell membrane. This crude extract then undergoes preliminary purification to remove major contaminants.

• Enzymatic Digestion and Final Purification

The extract is treated with a specific cocktail of enzymes, such as proteinase K, RNase, and DNase I, to digest and remove contaminating proteins and nucleic acids. This is followed by advanced chromatography to achieve the highest possible purity.

• Structural and Purity Analysis

The final purified product is subjected to a rigorous suite of analytical tests. We use HPLC and SDS-PAGE to confirm purity and homogeneity. For detailed structural analysis, we perform mass spectrometry to characterize the precise molecular structure of the carbohydrate.

Workflow

Case Study

Background

PGN is an essential heteropolymer forming the protective cell wall meshwork in both Gram-positive and Gram-negative bacteria. Structurally comprising glycan strands cross-linked by short peptide stems, its precise composition and bridging architecture vary significantly across species and dictate bacterial survival and antibiotic resistance. Elucidating the exact peptide configurations, amino acid mole percentages, and muropeptide oligomerization profiles represents a cornerstone in microbial physiology and antimicrobial drug target discovery. However, due to the highly cross-linked and insoluble nature of the native PGN matrix, capturing a complete structural blueprint requires high-efficiency enzymatic disassembly coupled with advanced multi-platform mass spectrometry.

Our Solution

CD BioGlyco deployed an orthogonal analytical solution featuring GC-MS for composition mapping alongside advanced Nanoflow LC-MS/MS for detailed muropeptide sequence resolution.

• Total Amino Acid Fingerprinting: Isolated PGN samples were subjected to intensive chemical hydrolysis followed by automated heptafluorobutyrate (HFB) derivatization. The volatile derivatives were profiled via high-sensitivity GC-MS against an integrated panel of reference standards to establish accurate amino acid mole percentages.
• Targeted Enzymatic Disassembly: Intact PGN frameworks from diverse bacterial sources, including Escherichia coli, were selectively fragmented using mutanolysin. This specific endo-β-N-acetylmuramidase cleaves the β1,4-glycosidic bonds between N-acetylmuramic acid and N-acetylglucosamine, yielding intact soluble muropeptides.
• Deep-Scale Muropeptide Sequencing: The resulting muropeptide monomers and oligomers were resolved on a C18 column using a VanquishNEO nanoflow LC system and fed into a high-resolution Orbitrap MS. The system executed high-accuracy full MS scans coupled with data-dependent top-down MS/MS fragmentation.

Results

The comprehensive dual analytical approach successfully deciphered the structural signature and species-specific variations of the bacterial cell walls:

• Cross-Linker Chemotype Differentiation: The GC-MS profile definitively mapped the amino acid landscape and successfully captured a critical taxonomic biomarker. E. coli demonstrated prominent peaks corresponding to the classic diamino acid linker diaminopimelic acid (DAP).

Fig.2 GC-MS chromatogram of the HFBA derivatized amino acids. (CD BioGlyco)

Table 1 Amount and mole percentage of each detected amino acid. (CD BioGlyco)

• High-Resolution Muropeptide Mapping: High-accuracy MS and data-dependent MS/MS spectra delivered an exhaustive inventory of the product pool, successfully profiling PGN monomers, dimers, and trimers. Utilizing specialized bioinformatic analysis via Byonic (v5.0) software combined with rigorous manual expert annotation, specific sequences and cross-linking motifs consistent with Gram-positive and Gram-negative literature profiles were fully mapped.

Fig.3 Example of Byonic assignment of a muropeptide monomer (AEmA-GlcNMurNAc) found in E. coli. (CD BioGlyco)

Table 2 Primary monomer assignments. (CD BioGlyco)

Table 3 Primary dimer assignments. (CD BioGlyco)

By bridging the gap between total chemical composition and intact oligomeric architecture, this advanced characterization workflow provided the client with definitive molecular profiles of their target bacterial cell walls. The resulting high-fidelity dataset successfully eliminated analytical ambiguity, accelerating the client's downstream antibacterial screening programs and structural biology pipelines.

Publication Data

Advantages

• Our rigorous multi-step purification protocols, including the use of enzymatic digestion and optimized chemical extraction, consistently yield highly pure carbohydrates with minimal contamination from proteins, lipids, and nucleic acids
• We provide in-depth structural analysis using state-of-the-art analytical tools, giving you confidence in the identity and quality of your material. Our techniques allow for the assessment of structural heterogeneity, which is critical for understanding biological activity.
• Our expertise with various extraction and purification techniques—from phenol-water to safer, modified protocols—allows us to select the optimal approach for your specific bacterial strain and research objective.

Application

• Since the peptidoglycan biosynthesis pathway is a primary target for many antibiotics, a detailed understanding of its structure is essential for studying antibiotic resistance mechanisms and developing new antimicrobial agents.
• Peptidoglycan fragments are recognized by host immune receptors (e.g., NOD-like receptors), making the structural analysis of PGN crucial for understanding innate immune responses and for developing effective vaccines.
• Characterizing peptidoglycan is fundamental for studying bacterial cell growth, cell division, and virulence.

Frequently Asked Questions

Associated Services

Building upon the expertise in intricate peptidoglycan purification and structural characterization, our analytical capabilities extend to a diverse range of polysaccharides from various natural sources. This specialized knowledge is directly applied in our comprehensive Polysaccharide Analysis Service, which includes, but is not limited to:

CD BioGlyco provides systematic and one-stop services for peptidoglycan structure research and ensure the continuity and transparency of the experimental process. We will continue to improve our standards to meet customers' glycobiology research needs with high quality.

Customers can contact our employees directly and we will respond promptly. If you are interested in our services, please contact us for more detailed information.

Reference

1. Hernández, S.B.; et al. Peptidoglycan editing in non-proliferating intracellular Salmonella as source of interference with immune signaling. PLoS pathogens. 2022, 18(1): e1010241. (Open Access)

Quick Links

Resources